Assignment of Assignor's Interest

Recorded: 2008-10-15 Pages: 11

Assignor

HOFMANN, ROBERT F.

Executed: 2008-10-06

Assignee

TORQUIN, LLC

5900 SW PARKWAY, SUITE 520, AUSTIN, TEXAS, 78735

Covered Properties (11)

Uses of Targeted Oxidative Therapeutic Formulation in Arteriosclerosis

Patent: 6,790,463 →

Application: 09/822,773 →

Publication: US 2002/0177585

Targeted Oxidative Therapeutic Formulation

Patent: 6,884,797 →

Application: 09/823,252 →

Publication: US 2003/0032677

Use of targeted oxidative therapeutic formulation in treatment of viral diseases

Application: 11/059,947 →

Publication: US 2005/0192267

Targeted oxidative therapeutic formulation

Application: 11/074,191 →

Publication: US 2005/0148568

Targeted Oxidative Therapeutic Formulation

Patent: 7,521,440 →

Application: 11/074,192 →

Publication: US 2005/0148569

Use of Targeted Oxidative Therapeutic Formulation in Treatment of Type 2 Diabetes

Patent: 7,414,044 →

Application: 11/122,907 →

Publication: US 2005/0272714

Use of Targeted Oxidative Therapeutic Formulation in Bone Regeneration

Patent: 7,572,782 →

Application: 11/125,773 →

Publication: US 2005/0250755

Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration

Application: 11/125,932 →

Publication: US 2005/0250756

Use of targeted oxidative therapeutic formulation in treatment of cancer

Application: 11/125,996 →

Publication: US 2005/0250757

Use of targeted oxidative therapeutic formulation in endodontic treatment

Application: 11/158,514 →

Publication: US 2006/0035881

Use of targeted oxidative therapeutic formulation in treatment of burns

Application: 11/158,997 →

Publication: US 2006/0014732